Burke PJ - Search Results

1

Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: a combined clinical and laboratory study.

Kaufmann SH, Karp JE, Burke PJ, Gore SD. Kaufmann SH, et al. Among authors: burke pj. Leuk Lymphoma. 1996 Sep;23(1-2):71-83. doi: 10.3109/10428199609054804. Leuk Lymphoma. 1996. PMID: 9021688 Clinical Trial.

2

Cure of acute myelocytic leukemia in adults: a reality.

Geller RB, Saral R, Karp JE, Santos GW, Burke PJ. Geller RB, et al. Among authors: burke pj. Leukemia. 1990 May;4(5):313-5. Leukemia. 1990. PMID: 2201825 Review.

3

Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.

Karp JE, Burke PJ, Donehower RC. Karp JE, et al. Among authors: burke pj. Leukemia. 1990 Aug;4(8):553-6. Leukemia. 1990. PMID: 2201833

4

Cures of leukemia with aggressive postremission treatment: an update of timed sequential therapy (Ac-D-Ac).

Burke PJ, Karp JE, Geller RB, Vaughan WP. Burke PJ, et al. Leukemia. 1989 Oct;3(10):692-4. Leukemia. 1989. PMID: 2674562

5

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia.

Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ. Kaufmann SH, et al. Among authors: burke pj. Blood. 1994 Jan 15;83(2):517-30. Blood. 1994. PMID: 7904487 Free article.

6

Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.

Rowinsky EK, Adjei A, Donehower RC, Gore SD, Jones RJ, Burke PJ, Cheng YC, Grochow LB, Kaufmann SH. Rowinsky EK, et al. Among authors: burke pj. J Clin Oncol. 1994 Oct;12(10):2193-203. doi: 10.1200/JCO.1994.12.10.2193. J Clin Oncol. 1994. PMID: 7931489 Clinical Trial.

7

Identification of growth factor-responsive acute myelogenous leukemia based on factor-dependence for survival and proliferation.

Gore SD, Weng LJ, Burke PJ. Gore SD, et al. Among authors: burke pj. Leukemia. 1994 Nov;8(11):1854-63. Leukemia. 1994. PMID: 7967731

8

Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery.

Gore SD, Donnenberg AD, Zehnbauer BA, Weng LJ, Burke PJ. Gore SD, et al. Among authors: burke pj. Leukemia. 1994 Mar;8(3):409-19. Leukemia. 1994. PMID: 8127146 Clinical Trial.

9

Topoisomerase II and the response to antileukemic therapy.

Kaufmann SH, Gore SD, Miller CB, Jones RJ, Zwelling LA, Schneider E, Burke PJ, Karp JE. Kaufmann SH, et al. Among authors: burke pj. Leuk Lymphoma. 1998 Apr;29(3-4):217-37. doi: 10.3109/10428199809068560. Leuk Lymphoma. 1998. PMID: 9684921 Review.

10

Impact of exogenous growth factors on proliferation and chemosensitivity of minimal residual acute myeloid leukemia.

Gore SD, Burke PJ, Weng LJ. Gore SD, et al. Among authors: burke pj. Leuk Lymphoma. 1998 Apr;29(3-4):339-50. doi: 10.3109/10428199809068570. Leuk Lymphoma. 1998. PMID: 9684931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters